The Business Research Company’s latest report Interventional Oncology Devices Global Market Report 2020 covers Interventional Oncology Devices market drivers, Interventional Oncology Devices market trends, Interventional Oncology Devices market segments, Interventional Oncology Devices market growth rate, Interventional Oncology Devices market major players, and Interventional Oncology Devices market size. The report provides in-depth analysis of the impact of COVID-19 on the Interventional Oncology Devices industry, along with revised market numbers due to the effects of the coronavirus.
View Complete Report:
Interventional Oncology Devices Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
Request for the sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp
The global interventional oncology device market is expected to decline from $2.13 billion in 2019 to $2.01 billion in 2020 at a compound annual growth rate (CAGR) of -5.39%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $2.75 billion in 2023 at a CAGR of 10.99%.
The report covers
the Interventional Oncology Devices market’s segments-
1) By Product:
Embolization Devices, Ablation Devices, Support Devices.
2) By Procedure:
Thermal Tumor Ablation, Non-thermal Tumor Ablation, Transcatheter Arterial
Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE) or
Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial
Embolization (TAE) or Bland Embolization.
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Others.
TBRC’s annual festive sale is finally here! Get up to 50% off on ALL reports: https://www.thebusinessresearchcompany.com/global-market-reports
About The Business Research Company:
The Business Research Company is a Business
Intelligence Company which excels in company, market and consumer research. It
has offices in the UK, the US and India and a network of trained researchers in
20 countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
No comments:
Post a Comment